← All states

Ketamine Clinics in Missouri

Missouri ketamine infusion clinics for treatment-resistant depression and chronic pain.

3 verified providers, mapped & reviewed.

Browse the map ↓
3
Clinics
3
Cities served
★ 4.87
Avg rating

Showing 3 of 3 clinics

Top 3 Other clinics
Updated Jun 2026

Top 3 in Missouri

Ranked by quality score (rating × review volume).

All Missouri clinics

ClinicCityRatingReviewsCategory
Morpheus IV Hydration & Ketamine Infusion ClinicColumbia4.878Medical clinic
Alive Med Spa & Ketamine ClinicKirkwood4.965Mental health clinic
Ketamine Clinic Rx - Mental Health & Pain TreatmentLee's Summit4.931Mental health clinic

Missouri regulations

Missouri Board of Healing Arts oversees ketamine prescribing. Spravato is FDA-approved and may be covered by Missouri Medicaid (MO HealthNet) for qualifying treatment-resistant depression patients.

Frequently asked questions

How many ketamine clinics are there in Missouri?+

Our directory tracks 3 verified, Google-listed ketamine and Spravato providers across Missouri, updated monthly from public business data.

Does insurance cover Spravato in Missouri?+

Spravato (esketamine) is FDA-approved for treatment-resistant depression and is increasingly covered by major insurers in Missouri when REMS protocol criteria are met. IV ketamine remains off-label and is rarely covered.

Do I need a referral to visit a Missouri ketamine clinic?+

Most Missouri clinics accept self-referral for IV ketamine, but Spravato typically requires a psychiatrist referral and documented treatment-resistant depression diagnosis.

What's the typical cost of ketamine treatment in Missouri?+

IV infusions in Missouri generally range $400–$800 per session, with most protocols calling for 6 initial sessions plus periodic boosters. Spravato copays vary by insurance plan.

What's the difference between IV ketamine and Spravato?+

IV ketamine (racemic) is delivered as an infusion in-clinic and used off-label for depression, PTSD, and chronic pain. Spravato (esketamine) is an FDA-approved intranasal spray for treatment-resistant depression and is covered by REMS — both must be administered in-clinic.